Edges in Network
| Network | GSE16987_egf1520 - GSE16987 - SiGN-BN HC+Bootstrap |
| Network Description | A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis |
| Node | EPHA2 |
| Upstream (Parents) |
|---|
| (<<) EGFR → EPHA2 |
| (<<) EGR1 → EPHA2 |
| (<<) EMP1 → EPHA2 |
| (<<) ID1 → EPHA2 |
| (<<) IGFBP3 → EPHA2 |
| (<<) KCNN4 → EPHA2 |
| (<<) KRT5 → EPHA2 |
| (<<) KRT6B → EPHA2 |
| (<<) NCOA7 → EPHA2 |
| (<<) NOTCH1 → EPHA2 |
| (<<) PLD1 → EPHA2 |
| (<<) SLC25A37 → EPHA2 |
| (<<) SLC6A14 → EPHA2 |
| (<<) ST3GAL6 → EPHA2 |
| (<<) TCF7L1 → EPHA2 |
| Downstream (Children) |
|---|
| EPHA2 → ANGPTL4 (>>) |
| EPHA2 → ARSJ (>>) |
| EPHA2 → CALM3 (>>) |
| EPHA2 → CDC42EP1 (>>) |
| EPHA2 → CXADR (>>) |
| EPHA2 → CXCL2 (>>) |
| EPHA2 → DNAJA4 (>>) |
| EPHA2 → DUSP5 (>>) |
| EPHA2 → EDN1 (>>) |
| EPHA2 → EPHA4 (>>) |
| EPHA2 → FZD4 (>>) |
| EPHA2 → GOT2 (>>) |
| EPHA2 → GRHPR (>>) |
| EPHA2 → HAS3 (>>) |
| EPHA2 → HYAL1 (>>) |
| EPHA2 → ITGB4 (>>) |
| EPHA2 → LIF (>>) |
| EPHA2 → LSM1 (>>) |
| EPHA2 → MAP3K6 (>>) |
| EPHA2 → PARD6G (>>) |
| EPHA2 → PCK2 (>>) |
| EPHA2 → PDRG1 (>>) |
| EPHA2 → PI3 (>>) |
| EPHA2 → PLCD1 (>>) |
| EPHA2 → PLK3 (>>) |
| EPHA2 → PTK7 (>>) |
| EPHA2 → RASD1 (>>) |
| EPHA2 → RRAS (>>) |
| EPHA2 → RYK (>>) |
| EPHA2 → S100A2 (>>) |
| EPHA2 → SLC5A1 (>>) |
| EPHA2 → SLPI (>>) |
| EPHA2 → SOD3 (>>) |
| EPHA2 → SPRY2 (>>) |
| EPHA2 → SYNJ2 (>>) |
| EPHA2 → TCEAL1 (>>) |
| EPHA2 → TNFRSF1A (>>) |
| EPHA2 → TSG101 (>>) |
| EPHA2 → UBE2N (>>) |
| EPHA2 → VTCN1 (>>) |
